Provision of harm reduction and drug treatment services in custodial settings – Findings from the European ACCESS study

References

• Aebi, M.F., & Delgrande, N. (2014). SPACE I – Council of Europe annual penal statistics: Prison populations. Survey 2012. Strasbourg: Council of Europe
   Google Scholar
• Ahmadvand, A., Sepehrmanesh, Z., Sadat-Ghoreyshi, F., & Zahiroddin, A. (2009). Therapeutic effect of methadone on improving symptoms of depression in prisoners with a history of substance misuse. Iranian Journal of Psychiatry and Behavioral Sciences, 3, 29–32
   Google Scholar
• Allen, S.A., Spaulding, A.C., Osei, A.M., Taylor, L.E., Cabral, A.M., & Rich, J.D. (2003). Treatment of chronic hepatitis C in a state correctional facility. Annals of Internal Medicine, 138, 187–190
   PubMed Web of Science ®Google Scholar
• Asli, A.A., Moghadami, M., Zamiri, N., Tolide-ei, H.R., Heydari, S.T., Alavian, S.M., & Lankarani K.B. (2011). Vaccination against hepatitis B among prisoners in Iran: Accelerated vs. classic vaccination. Health Policy, 100, 297–304
   PubMed Web of Science ®Google Scholar
• Barocas, J.A., Baker, L., Hull, S.J., Stokes, S., & Westergaard, R.P. (2015). High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug and Alcohol Dependence, 154, 283–286
   PubMed Web of Science ®Google Scholar
• Bauserman, R.L., Richardson, D., Ward, M., Shea, M., Bowlin, C., Tomoyasu, N., & Solomon, L. (2003). HIV prevention with jail and prison inmates: Maryland's prevention case management program. AIDS Education and Prevention, 15, 465–480
   PubMed Web of Science ®Google Scholar
• Bennet, T., & Holloway, K. (2012). The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: An evaluation of the THN project in Wales. Drugs: Education, Prevention & Policy, 19, 320–328
   Web of Science ®Google Scholar
• Braithwaite, R., Stephens, T.T., Treadwell, H., Braithwaite, K., & Conerly, R. (2005). Short-term impact of an HIV risk reduction intervention for soon-to-be-released inmates in Georgia. Journal of Health Care for the Poor and Underserved, 16, 130–139
   PubMed Web of Science ®Google Scholar
• Chew, K., Allen, S., Taylor, L., Rich, J., & Feller, E. (2009). Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C. Journal of Clinical Gastroenterology, 43, 686–691
   PubMed Web of Science ®Google Scholar
• Dolan, K., Rutter, S., & Wodak, A. (2003b). Prison-based syringe exchange programmes: A review of international research and development. Addiction, 98, 153–158
   PubMed Web of Science ®Google Scholar
• Dolan, K., Shearer, J., MacDonald, M., Mattick, R.P., Hall, W., & Wodak, A.D. (2003a). A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug and Alcohol Dependence, 72, 59–65
   PubMed Web of Science ®Google Scholar
• Dolan, K., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction, 100, 820–828
   PubMed Web of Science ®Google Scholar
• Dolan, K.A., Bijl, M., & White, B. (2004). HIV education in a Siberian prison colony for drug dependent males. International Journal for Equity in Health, 3, 7
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2012). Prisons and drugs in Europe: The problem and responses. Selected Issue. Lisbon: EMCDDA
   Google Scholar
• Farley, J., Vasdev, S., Fischer, B., Haydon, E., Rehm, J., & Farley, T. (2005). Feasibility and outcome of HCV treatment in a Canadian federal prison population. American Journal of Public Health, 95, 1737–1739
   PubMed Web of Science ®Google Scholar
• Farrell, M., & Marsden, J. (2007). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction, 103, 251–255
   Web of Science ®Google Scholar
• Fazel, S., Bains, P., & Doll, H. (2006). Substance abuse and dependence in prisoners. A systematic review. Addiction, 101, 181–191
   PubMed Web of Science ®Google Scholar
• Gilbert, R.L., O'Connor, T., Mathew, S., Allen, K., Piper, M., & Gill, O.N. (2004). Hepatitis A vaccination – A prison-based solution for a community-based outbreak? Communicable Disease and Public Health, 7, 289–293
   PubMedGoogle Scholar
• Hedrich, D., Alves, P., Farrell, M., Stoever, H., Moller, L., & Mayet, S. (2012). The effectiveness of opioid maintenance treatment in prison settings: A systematic review. Addiction, 107, 501–517
   PubMed Web of Science ®Google Scholar
• Hickman, M., McDonald, T., Judd, A., Nichols, T., Hope, V., Skidmore, S., & Parry, J.V. (2008). Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: A cluster randomized controlled trial. Journal of Viral Hepatitis, 15, 250–254
   PubMed Web of Science ®Google Scholar
• Howells, C., Allen, S., Gupta, J., Stillwell, G., Marsden, J., & Farrell, M. (2002). Prison based detoxification for opioid dependence: A randomised double blind controlled trial of lofexidine and methadone. Drug and Alcohol Dependence, 67, 169–176
   PubMed Web of Science ®Google Scholar
• Juergens, R., Ball, A., & Verster, A. (2009). Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infectious Diseases, 9, 57–66
   PubMed Web of Science ®Google Scholar
• Kinlock, T.W., Gordon, M.S., Schwartz, R.P., Fitzgerald, T.T., & O'Grady, K.E. (2009). A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease. Journal of Substance Abuse Treatment, 37, 277–285
   PubMed Web of Science ®Google Scholar
• Kinlock, T.W., Gordon, M.S., Schwartz, R.P., O'Grady, K., Fitzgerald, T.T., & Wilson, M. (2007). A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91, 220–227
   PubMed Web of Science ®Google Scholar
• Kinner, S.A., Moore, E., Spittal, M.J., & Indig, D. (2013). Opiate substitution treatment to reduce in-prison drug injection: A natural experiment. International Journal of Drug Policy, 24, 460–463
   PubMed Web of Science ®Google Scholar
• Larney, S. (2010). Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. Addiction, 105, 216–223
   PubMed Web of Science ®Google Scholar
• Larney, S., & Dolan, K. (2009). A literature review of international implementation of opioid substitution treatment in prisons: Equivalence of care? European Addiction Research, 15, 107–112
   PubMed Web of Science ®Google Scholar
• Larney, S., Toson, B., Burns, L., & Dolan, K. (2012). Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. Addiction, 107, 372–380
   PubMed Web of Science ®Google Scholar
• Lines, R., Juergens, R., Betteridge, G., Stöver, H., Laticevschi, D., & Nelles, J. (2004). Prison needle exchange: Lessons from a comprehensive review of international evidence and experience: Canadian HIV/AIDS Legal Network
   Google Scholar
• Lines, R., Jurgens, R., Betteridge, G., & Stover, H. (2005). Taking action to reduce injecting drug-related harms in prisons: The evidence of effectiveness of prison needle exchange in six countries. International Journal of Prisoner Health, 1, 49–64
   Google Scholar
• Lloyd, A.R., Clegg, J., Lange, J., Stevenson, A., Post, J.J., Lloyd, D., … Monkley D. (2013). Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis c in the custodial setting. Clinical Infectious Diseases, 56, 1078–1084
   PubMed Web of Science ®Google Scholar
• Lubelczyk, R.A., Friedmann, P.D., Lemon, S.C., Stein, M.D., & Gerstein, D.R. (2002). HIV prevention services in correctional drug treatment programs: Do they change risk behaviors? AIDS Education and Prevention, 14, 117–125
   PubMed Web of Science ®Google Scholar
• Maru, D., Bruce, R., Basu, S., & Altice, F. (2008). Clinical outcomes of hepatitis C treatment in a prison settting: Feasibility and effectiveness for challenging treatment populations. Clinical Infectious Diseases, 47, 952–961
   PubMed Web of Science ®Google Scholar
• McGovern, B., Fiore, J., Wurcel, A., Taglienti, P., Bradley, M., Galvin, S., … Bica I. (2005). Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients. Clinical Infectious Diseases, 41, 56–62
   PubMed Web of Science ®Google Scholar
• McKenzie, M., Zaller, N., Dickman, S.L., Green, T.C., Parihk, A., Friedmann, P.D., & Rich, J.D. (2012). A randomized trial of methadone initiation prior to release from incarceration. Substance Abuse, 33, 19–29
   PubMed Web of Science ®Google Scholar
• Michel, L., Carrieri, M.P., Wodak, A. (2008). Harm reduction and equity of access to care for French prisoners: A review. Harm Reduction Journal, 5, 17
   PubMed Web of Science ®Google Scholar
• Perrett, S. (2011). Prisoner health: Assessing a nurse-led hepatitis C testing clinic. British Journal of Nursing, 20, 611–614
   PubMedGoogle Scholar
• Rosen, D.L., Schoenbach, V.J., Wohl, D.A., White, B.L., Stewart, P.W., Golin, C.E. (2009). An evaluation of HIV testing among inmates in the North Carolina prison system. American Journal of Public Health, 99, 452–459
   PubMed Web of Science ®Google Scholar
• Saber-Tehrani A.S., Springer S.A., Qiu J., Herme M., Wickersham J., & Altice F.L. (2012). Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community – A potential conduit to improved HIV treatment outcomes. Contemporary Clinical Trials, 33, 436–444
   PubMed Web of Science ®Google Scholar
• Shaw, J., Appleby, L., & Baker, D. (2003). Safer prisons: A national study of prison suicides 1999–2000 by the national confidential inquiry into suicides and homicides by people with mental illness. London: Department of Health
   Google Scholar
• Sheard, L., Wright, N.M., El-Sayeh, H.G., Adams, C.E., Li, R., Tompkins, C.N. (2009). The leeds evaluation of efficacy of detoxification study (LEEDS) prisons project: A randomised controlled trial comparing dihydrocodeine and buprenorphine for opiate detoxification. Substance abuse treatment, prevention, and policy, 4, 1
   PubMed Web of Science ®Google Scholar
• Skipper, C., Guy, J., Parkes, J., Roderick, P., & Rosenberg, W. (2003). Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: Implications for the national strategy. Gut, 52, 1500–1504
   PubMed Web of Science ®Google Scholar
• Stoever, H., & Nelles, J. (2003). Ten years of experience with needle and syringe exchange programmes in European prisons. International Journal of Drug Policy, 14, 437–444
   Google Scholar
• Stöver, H., & Zurhold, H. (2014). Access to treatment for drug users within the criminal justice system in European countries. Systematic literature review, existing harm reduction initiatives in prisons, and models of good practice (ACCESS). Oldenburg: BIS-Verlag der Carl von Ossietzky Universität Oldenburg
   Google Scholar
• Sutton, A.J., Gay, N.J., Edmunds, W.J., Andrews, N.J., Hope, V.D., Gilbert, R.L., … Gill ON. (2006). Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection, 134, 231–242
   PubMed Web of Science ®Google Scholar
• UNODC. (2012). HIV prevention, treatment and care in prisons and other closed settings: A comprehensive package of interventions. Policy Brief. Vienna: United Nations office on drugs and crime (UNODC)
   Google Scholar
• Verger, P., Rotily, M., Prudhomme, J., & Bird, S. (2003). High mortality rates among inmates during the year following their discharge from a French prison. Journal of Forensic Science, 48, 614–616
   PubMed Web of Science ®Google Scholar
• WHO. (2007). Health in prisons: A WHO guide to the essentials in prison health. Copenhagen, WHO Regional Office for Europe
   Google Scholar
• WHO. (2014). Prisons and Health. Copenhagen, World Health Organization, Regional Office for Europe
   Google Scholar
• Wilson, M.E., Kinlock, T.W., Gordon, M.S., O'Grady, K.E., & Schwartz, R.P. (2012). Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners. American Journal on Addictions, 21, 476–487
   PubMed Web of Science ®Google Scholar
• Winter, R.J., Stoové, M., Degenhardt, L., Hellard, M.E., Spelman, T., Jenkinson, R., … Kinner S.A. (2015). Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia. Drug and Alcohol Dependence, 153, 43–49
   PubMed Web of Science ®Google Scholar
• Wright, N.M., Sheard, L., Adams, C.E., Rushforth, B.J., Harrison, W., Bound, N., … Tompkins CN. (2011). Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): A randomised controlled trial. British Journal of General Practice, 61, e772–e780
   PubMed Web of Science ®Google Scholar